Super-sensitive protein measurement assay for CRO Eurofins

By Fiona BARRY contact

- Last updated on GMT

The assay can measure proteins at femtogram levels. (Image: Havar og Solvelg)
The assay can measure proteins at femtogram levels. (Image: Havar og Solvelg)

Related tags: Pharmacology

Eurofins Bioanalytical Services has announced it will offer an extra-sensitive immunoassay service for biopharma developers.

The Singulex Erenna Immunoassay system can detect proteins at the femtogram (10−15​g) level, allowing measurements of extremely low levels of protein, the contract research organisation (CRO) said.

The tool is used in pharmacokinetic studies to measure biomarkers and evaluate the immune response to large molecule drugs. Detecting very small levels of protein in biopharmaceuticals can be a challenge.

The Erenna immunoassay system, powered by Singulex’s SMC technology, provides unprecedented quantification of protein targets at low and high abundance, providing a complete data set for a sponsor to make informed decisions and accelerate program success,​” said Paul Wheeler, VP, Life Science Sales and Marketing at Singulex.

Eurofins is a trusted outsourcing partner for many in the pharma industry, and we are pleased that they have added the Erenna system to their Bioanalytical Lab Services offering.​”

Eurofins Bioanalytical Serrvices has already partnered with several of our clients to develop and transfer novel methods on the Erenna system.​” said Dr Jim Hulse, General Manager of Eurofins Bioanalytical Services. “We look forward to working with additional users of the platform as we begin offering services using the existing biomarker assay kits available from Singulex.​”

Pall​ and Selvita​ have also recently invested in their bioassay platforms for large molecule drug development services.  

Bio-outsourcing is on the rise, reports show,​ with analytical testing – such as assays – topping the list of tasks pharma companies are willing to send out of house.

Related news

Show more

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q² Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Related suppliers

Follow us


View more